Genetalks Biotechnology (Changsha) Co., Ltd.

Genetalks Biotechnology (Changsha) Co., Ltd. (Genetalks) is a biotech high-tech company dedicated to the technology translation of genetic testing, diagnosis, and immunotherapy for genetic diseases and cancer, and provides safe and efficient clinical solutions and comprehensive customer support. The company's team initiated research on next-generation sequencing technology in a laboratory in San Diego, USA in 2009, and officially returned to China in 2014 to establish Genetalks Biotechnology Co., Ltd. The company has a professional, dedicated, open, diverse, and passionate entrepreneurial team. Its core members come from renowned universities and institutions such as Cornell, Yale, Goldman Sachs, IDG, and Eli Lilly, and it has a professional talent team comprised of returned overseas Ph.D.s, master's degree holders, and industry experts in research and development, production, management, and sales. The company's goal is to use internationally aligned clinical genetic testing services to accumulate multi-dimensional health data, and to use computing and data mining capabilities to build health risk models. Bioinformatics analysis cloud platform, etc. At present, based on leading gene sequencing and Bio-IT technologies, it has formed multiple global patents and market applications in areas such as tumor liquid biopsy, large-scale health population genetic big data construction, and biological computing acceleration. It has built a third-party clinical testing platform with international standards and has become a gene testing technology demonstration center of the National Development and Reform Commission. In 2014, the company reached a strategic cooperation with Xiangya Medical Laboratory on the clinical application of high-throughput gene sequencing, and through the 3,000-square-meter Genetalks independent medical laboratory, it has conducted in-depth research and development and technology output for technologies including non-invasive prenatal genetic testing, preimplantation screening, and circulating tumor DNA detection. Through the clinical testing services of Xiangya Medical Laboratory and Changsha Genetalks Medical Laboratory, it has reached in-depth technical service cooperation with major domestic medical institutions, becoming a solid guarantee for partner hospitals to efficiently, comprehensively, and personalizedly carry out gene sequencing research and clinical services.